News

UM Brain Disorder Research Moves Toward Clinical Testing – Promentis Pharmaceuticals, Inc.

February 10, 2015 /

MATR Sponsor (view all)


Dorsey & Whitney - An International business law firm, applying a business perspective to clients' needs in Missoula, Montana and beyond.

University of Montana is one step closer to turning a discovery into a drug.

Promentis Pharmaceuticals, Inc. http://www.promentispharma.com/ recently announced it will enter an exclusive agreement with UM to commercialize a discovery made by a team of UM faculty scientists that has the potential to treat brain cancer and possibly other disorders of the central nervous system.

The team, which is based in the Department of Biomedical and Pharmaceutical Sciences within UM’s Skagg’s School of Pharmacy, includes professors Richard Bridges, Sarjubhai Patel, Nicjholas Natale, Philippe Diaz and Charles Thompson.

http://news.umt.edu/2015/02/020915pharm.php

MATR Supporters (view all)


The Kalispell Chamber of Commerce is the longest-standing and leading advocate for the Flathead Valley community and business climate.

Big Sky EDA- Building Businesses and Creating Jobs in the Greater Billings, Montana area

SBA 504 Loans offered statewide! Real estate and equipment, acquisitions, renovation, and new construction. Low, fixed-rates up to 25 years with as little as 10% down.
Posted in:

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.